10-Q: Chemed Corporation Reports Mixed Q3 Results: VITAS Growth Offsets Roto-Rooter Decline

Chemed Corporation's third-quarter results show strong growth in its VITAS hospice segment, which was partially offset by a decline in Roto-Rooter's revenue.

Summary

• Chemed Corporation's Q3 2024 results show a 7.4% increase in consolidated service revenues and sales compared to Q3 2023, reaching $606.2 million.
• This growth was driven by a 17.3% increase in VITAS revenues, which was partially offset by a 6.9% decrease in Roto-Rooter revenues.
• VITAS's revenue growth was primarily due to a 15.5% increase in days-of-care and a 2.6% increase in Medicare reimbursement rates.
• Roto-Rooter experienced a decrease in all service lines, contributing to the overall revenue decline.
• Net income for the quarter was $75.8 million, slightly up from $75.0 million in the same period last year.
• For the first nine months of 2024, consolidated service revenues and sales increased by 6.7% to $1.79 billion, with VITAS up 16.1% and Roto-Rooter down 5.9%.
• The company estimates full-year 2024 adjusted earnings per diluted share to be in the range of $23.00 to $23.15, representing a 13.3% to 14.0% increase from 2023.

Sentiment

Score: 6

Explanation: The document presents a mixed picture with strong growth in the VITAS segment offset by weakness in Roto-Rooter. The overall tone is cautiously optimistic, but the challenges in the Roto-Rooter segment and regulatory risks temper the positive outlook.

Positives

• VITAS's strong revenue growth of 17.3% in Q3 2024 demonstrates the strength of the hospice care segment.
• The acquisition of Covenant Care is expected to contribute to future revenue and earnings growth.
• The company's adjusted EBITDA increased to $123 million in Q3 2024, up from $116 million in Q3 2023.
• Chemed is in compliance with all debt covenants as of September 30, 2024.
• The company has $404.8 million of unused lines of credit available.

Negatives

• Roto-Rooter's revenue declined by 6.9% in Q3 2024, indicating weakness in the plumbing and drain cleaning segment.
• The consolidated gross margin decreased to 34.6% in Q3 2024 from 35.8% in Q3 2023.
• Roto-Rooter's net income was negatively impacted by declining revenue and higher SG&A expenses.
• Hurricane Helene negatively impacted VITAS admissions by an estimated 60-100 patients.

Risks

• VITAS operates in a heavily regulated industry and is subject to audits and investigations by government agencies.
• The company is subject to various lawsuits and claims in the normal course of business.
• A significant portion of VITAS's accounts receivable is from Medicare and Medicaid, making it vulnerable to changes in government programs.
• The company is exposed to interest rate risk through its variable interest line of credit.
• The company is subject to the risk of being selected for the hospice Special Focus Program (SFP), which could negatively impact its brand reputation and increase compliance costs.

Future Outlook

Chemed estimates full-year 2024 adjusted earnings per diluted share to be in the range of $23.00 to $23.15, representing a 13.3% to 14.0% increase from 2023.

Management Comments

• Management continually evaluates cash utilization alternatives, including share repurchase, debt repurchase, acquisitions and increased dividends to determine the most beneficial use of available capital resources.
• Management believes its liquidity and sources of capital are satisfactory for the Company's needs in the foreseeable future.

Industry Context

The hospice care industry is experiencing growth, as evidenced by VITAS's strong performance. The plumbing and drain cleaning industry, represented by Roto-Rooter, is facing some headwinds, as indicated by the revenue decline.

Comparison to Industry Standards

• VITAS's revenue growth of 17.3% in Q3 2024 is strong compared to the overall hospice industry, which is experiencing growth due to an aging population and increased acceptance of hospice care.
• Roto-Rooter's revenue decline of 6.9% in Q3 2024 is below the average performance of the plumbing and drain cleaning industry, which is generally considered stable but can be impacted by economic conditions and consumer spending.
• Comparable companies in the hospice sector include LHC Group and Amedisys, which have also reported growth in recent periods, although specific growth rates may vary.
• Comparable companies in the plumbing and drain cleaning sector include publicly traded franchises such as Mr. Rooter and Benjamin Franklin Plumbing, which have shown mixed results depending on their geographic locations and business models.

Legal Proceedings

• VITAS is one of a group of hospice providers selected by the Office of the Inspector Generals (OIG) Office of Audit Services (OAS) for inclusion in an audit of the provision of elevated level-of-care hospice services.
• VITAS received a demand letter from its Medicare Administrative Contractor (MAC) seeking repayment of $50.3 million.
• The company is subject to various lawsuits and claims in the normal course of business.

Stakeholder Impact

• Shareholders may be concerned about the decline in Roto-Rooter's revenue but encouraged by the growth in VITAS and the overall earnings guidance.
• Employees at VITAS may benefit from the company's growth, while those at Roto-Rooter may face uncertainty due to the revenue decline.
• Customers of VITAS will continue to receive hospice care services, while customers of Roto-Rooter may experience changes in service availability or pricing.
• Suppliers to VITAS and Roto-Rooter may be impacted by changes in the company's operations and financial performance.
• Creditors of Chemed will be interested in the company's compliance with debt covenants and its ability to generate cash flow.

Next Steps

• The company will continue to monitor the performance of both VITAS and Roto-Rooter segments.
• Management will evaluate cash utilization alternatives, including share repurchase, debt repurchase, acquisitions, and increased dividends.
• The company will continue to defend itself against ongoing legal and regulatory matters.
• The company will monitor the potential impact of the hospice Special Focus Program (SFP).

Key Dates

Keywords

hospice care, plumbing services, drain cleaning, VITAS Healthcare, Roto-Rooter, revenue, EBITDA, acquisitions, Medicare, financial results